Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495).
D000328:Adult; D000368:Aged; D001158:Arteries; D001161:Arteriosclerosis / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000188:drug therapy; D005260:Female; D006801:Humans; D008124:Locomotion / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D059408:Pain Management; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D010991:Plethysmography; D011087:Polycythemia Vera / Q000188:drug therapy; D011928:Raynaud Disease / Q000188:drug therapy; D013919:Thromboangiitis Obliterans / Q000188:drug therapy; D013923:Thromboembolism / Q000188:drug therapy; D014456:Ulcer / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010879:Piperazines; D014665:Vasodilator Agents